22 Aug 2024
Incretin Hormones: A New Avenue Against Diabetes
This article by Dr. Wiam I Hussein explores the promising role of incretin hormones in the treatment of type 2 diabetes. Incretin hormones, such as GLP-1 mimetics and DPP-4 inhibitors, are gaining attention in clinical studies for their effectiveness in managing postprandial blood glucose levels, which are critical in the early stages of type 2 diabetes. These agents address key pathophysiological defects in diabetes by enhancing insulin secretion and reducing insulin resistance, offering a new therapeutic approach that could reduce the need for painful insulin injections. The article highlights the ongoing need for new therapies to combat the increasing burden of type 2 diabetes, emphasizing the potential of incretin hormones to improve patient outcomes.